PURPOSE: Non-specific extracellular contrast agents have been on the market for more than 15 years. Here, we report on the synthesis of new selective lectin-gadolinium (Gd)-loaded chitosan nanoparticles with a prolonged clearance time and a much higher relaxivity in comparison to other preparations. PROCEDURES: Chitosan nanoparticles were prepared from 85% deacetylated chitin by glutaraldehyde cross-linking of an aqueous acetic acid dispersion of chitosan in a mixture of n-hexane using sodium bis(ethylhexyl)sulfosuccinate as a surfactant. RESULTS: Several crucial parameters, namely, the Gd and protein content of the nanoparticles, their size and dispersity were determined. Magnetic resonance measurements were carried out by intravenous perfusion of mono-disperse suspensions of the nanoparticles into mice. CONCLUSIONS: Chitosan nanoparticles can be used as contrast agents in magnetic resonance imaging (MRI). They are excellent candidates for controlled delivery of bioactive compounds to molecular targets and as biospecific diagnostic tools in MRI.
PURPOSE: Non-specific extracellular contrast agents have been on the market for more than 15 years. Here, we report on the synthesis of new selective lectin-gadolinium (Gd)-loaded chitosan nanoparticles with a prolonged clearance time and a much higher relaxivity in comparison to other preparations. PROCEDURES: Chitosan nanoparticles were prepared from 85% deacetylated chitin by glutaraldehyde cross-linking of an aqueous acetic acid dispersion of chitosan in a mixture of n-hexane using sodium bis(ethylhexyl)sulfosuccinate as a surfactant. RESULTS: Several crucial parameters, namely, the Gd and protein content of the nanoparticles, their size and dispersity were determined. Magnetic resonance measurements were carried out by intravenous perfusion of mono-disperse suspensions of the nanoparticles into mice. CONCLUSIONS: Chitosan nanoparticles can be used as contrast agents in magnetic resonance imaging (MRI). They are excellent candidates for controlled delivery of bioactive compounds to molecular targets and as biospecific diagnostic tools in MRI.
Authors: Gregory M Lanza; Dana R Abendschein; Xin Yu; Patrick M Winter; Kerry K Karukstis; Michael J Scott; Ralph W Fuhrhop; David E Scherrer; Samuel A Wickline Journal: Acad Radiol Date: 2002-08 Impact factor: 3.173
Authors: R Brasch; C Pham; D Shames; T Roberts; K van Dijke; N van Bruggen; J Mann; S Ostrowitzki; O Melnyk Journal: J Magn Reson Imaging Date: 1997 Jan-Feb Impact factor: 4.813
Authors: G M Lanza; C H Lorenz; S E Fischer; M J Scott; W P Cacheris; R J Kaufmann; P J Gaffney; S A Wickline Journal: Acad Radiol Date: 1998-04 Impact factor: 3.173
Authors: Xiongqi Han; Jianpan Huang; Anthea K W To; Joseph H C Lai; Peng Xiao; Ed X Wu; Jiadi Xu; Kannie W Y Chan Journal: Theranostics Date: 2020-01-12 Impact factor: 11.556
Authors: Unzila Yasin; Muhammad Bilal; Hamid Bashir; Muhammad Imran Amirzada; Aleena Sumrin; Muhammad Hassham Hassan Bin Asad Journal: Biomed Res Int Date: 2020-10-22 Impact factor: 3.411